| Condition | Key Finding | Association | Board Exam Tip |
| Medulloblastoma | CSF spread; Vermis mass | Pediatric CNS tumor; midline location | Always suspect medulloblastoma when a pediatric brain/spinal mass shows evidence of leptomeningeal seeding or CSF dissemination. |
| TMP-SMX Toxicity | Hyperkalemia; Bone marrow suppression | {Na}^+/{K}^+ exchange blocker (hyperkalemia); Folate antagonism (bone marrow) | Remember the mechanism: blocking E NaC leads to K+ retention. Rescue from bone marrow toxicity uses Leucovorin. |
| Hereditary Spherocytosis | Elevated MCHC; Osmotic fragility test positive | Membrane defect (Spectrin, Band 3); Extravascular hemolysis | The definitive treatment is splenectomy because the spleen macrophages are responsible for destruction. |
| Fibromuscular Dysplasia (FMD) | Stenosis/pseudoaneurysm in renal arteries | Affects the media layer; non-atherosclerotic vasculitis | If a young patient has resistant hypertension and vascular stenosis, think FMD first due to its medial wall involvement. |
| Topic | Key Point | Context | Exam Relevance |
| Medulloblastoma | CSF spread from vermis | Pediatric CNS tumor; midline location | High yield for board exams; emphasizes the mechanism of dissemination through cerebrospinal fluid. |
| TMP-SMX Toxicity | Hyperkalemia (K+ retention) | Blocks {Na}^+ absorption in collecting duct principal cells ({E NaC}); mimics Amiloride/Triamterene effect. | Critical drug interaction to remember; leads to Type 4 RTA picture. |
| Hereditary Spherocytosis | Splenectomy is treatment of choice | Membrane defects (Spectrin, Band 3) -> spherocytes -> extravascular hemolysis | The spleen's macrophages are the primary site of destruction; removal stops the cycle. |
| FMD vs Atherosclerosis | Media layer defect vs Intima layer plaque | Resistant hypertension in young patients | Knowing the specific vascular layer affected is key to differentiating these two causes of renal artery stenosis. |
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| Pediatric mass in the cerebellar vermis with diffuse spinal cord involvement, especially following CSF spread. | Medulloblastoma | The tumor's predilection for the midline and its ability to travel through CSF pathways is highly characteristic. |
| Young patient on TMP-SMX who develops profound bone marrow suppression requiring rescue therapy. | Folate antagonism/Bone Marrow Suppression | TMP-SMX inhibits dihydrofolate reductase, blocking folate synthesis; Leucovorin (folenic acid) bypasses this block. |
| Resistant hypertension in a young female with palpable thrill and bruit over the renal arteries. | Fibromuscular Dysplasia (FMD) | FMD is a non-atherosclerotic vasculitis affecting the medial layer of medium-sized arteries, often presenting as pseudoaneurysm/stenosis. |
| European boy with chronic anemia, recurrent jaundice, and episodes of red urine/pain after blood transfusions. | Hereditary Spherocytosis (HS) | Classic triad: membrane defect -> spherocytes -> extravascular hemolysis -> splenomegaly/jaundice. Splenectomy is curative. |
| Hypoglycemia accompanied by a hypoketotic state in the setting of fasting or prolonged NPO status. | Fatty Acid Oxidation Defect | Failure to beta-oxidize fatty acids prevents acetyl-CoA generation, which is necessary for ketogenesis. |
| Key Features | Distinguishing Findings | Next Step |
| Sydenham's Chorea | Choreiform movements only; follows Group A Strep infection (usually). | Clinical correlation with recent strep infection. |
| PANDAS | Choreiform movements + significant neuropsychiatric symptoms (e.g., OCD, tics); weeks/months after initial infection. | Rule out other causes of psychosis/tics; consider antibiotics if triggered by infection. |
| Key Features | Distinguishing Findings | Next Step |
| FMD | Affects the smooth muscle layer (media) of medium-sized arteries (e.g., renal, carotid). | Angiography showing characteristic "string of beads" appearance. |
| Atherosclerosis | Plaque buildup in the innermost lining (intima) of large/medium arteries. | Risk factor assessment (smoking, diabetes); High-intensity statin therapy. |
| Key Features | Distinguishing Findings | Next Step |
| Hereditary Spherocytosis | Membrane defect; spherocytes on smear; elevated MCHC; positive osmotic fragility test. | Genetic testing for membrane proteins (Spectrin, Band 3). |
| AIHA | Immune-mediated destruction; agglutination/spherocytes; often associated with warm autoantibodies ({IgG}). | Direct Antiglobulin Test (DAT) positive; immunosuppression (steroids, rituximab). |
🚨In hemolytic anemias (e.g., HS, sickle cell), the high red blood cell turnover rate necessitates daily folate supplementation to prevent deficiency.
🚨The MCHC is calculated as Mass of Hemoglobin / Volume of RBC; in spherocytosis, volume decreases while mass remains constant, thus increasing concentration.
| Condition | Association | Mechanism | Clinical Significance |
| Hereditary Spherocytosis | Splenectomy | Macrophages in the spleen are responsible for removing abnormal red blood cells (extravascular hemolysis). | Splenectomy is curative and reduces the risk of portal hypertension/gallstones. |
| TMP-SMX Toxicity | Hyperkalemia | Blocks {Na}^+/{K}^+ exchange ({E NaC}) in collecting duct principal cells, preventing K+ excretion. | Requires monitoring of serum potassium; treat with potassium binders if severe. |
| PANDAS | Molecular Mimicry | Antibodies generated against Group A Strep antigens cross-react with basal ganglia antigens. | Suggests an autoimmune etiology triggered by infection, requiring careful management and sometimes antibiotics. |
| Fatty Acid Oxidation Defect | Hypoglycemia + Hypoketotic state | Failure of beta-oxidation prevents acetyl-CoA formation needed for ketogenesis. | Distinguishes this metabolic crisis from simple starvation (which is typically hypoketotic but may have normal glucose). |
| Term | Definition | Context | Example |
| Spherocyte | Red blood cell lacking central pallor, appearing round and dense. | Hemolytic anemia; membrane defects (e.g., HS). | Seen on peripheral smear in Hereditary Spherocytosis. |
| MCHC | Mean Corpuscular Hemoglobin Concentration ({Mass of Hb} / {Volume of RBC}). | Hematology lab value. | Elevated MCHC is characteristic of spherocytes due to volume loss. |
| Leucovorin | Folenic acid (a biologically active form of folic acid). | Rescue therapy for folate antagonism. | Used to treat bone marrow suppression caused by TMP-SMX or sulfonamides. |
| Media Layer | The smooth muscle layer of an artery wall. | Vascular pathology; FMD affects this layer. | Fibromuscular Dysplasia is characterized by defects in the media, not the intima. |
| Topic | Study Approach | Priority | Resources |
| Drug Toxicities (TMP-SMX) | Focus on mechanism of action and resulting electrolyte/metabolic derangement. | High | Review nephrology drug tables; practice questions linking drugs to specific ion channels ({E NaC}). |
| Vascular Pathology | Create a comparison table comparing the layers affected by different diseases (Intima vs Media). | Medium-High | Use diagrams of arterial cross-sections; compare atherosclerosis, FMD, and vasculitis. |
| Hematology/Blood Smear | Master the key findings for common anemias: cell shape, MCHC, diagnostic test (e.g., osmotic fragility). | High | Practice interpreting blood smears and correlating them with underlying membrane defects or immune processes. |
🚫Mistake: Assuming all causes of resistant hypertension are due to advanced atherosclerosis. Correction: Always rule out FMD, especially in younger patients, because it affects the medial layer.
🚫Mistake: Confusing the mechanism of hyperkalemia from TMP-SMX with potassium wasting (like loop diuretics). Correction: TMP-SMX blocks \text{Na}^+ reabsorption, preventing the normal \text{K}^+ excretion that occurs alongside \text{Na}^+ absorption.